IRulya Therapeutics QNCX
NASDAQ QNCX
$40.27 +5.82 (+16.89%)
At close: Oct 20, 2026 · 4:00 PM EDT

Quince Therapeutics, Inc. (QNCX) Liabilities and Shareholders Equity (2018 - 2026)

Updated

Analysis

Quince Therapeutics, Inc. (QNCX) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 124.00 Mn
Mar 31, 2026 26.62 Mn
Dec 31, 2025 93.52 Mn
Sep 30, 2025 109.90 Mn
Jun 30, 2025 117.21 Mn
Mar 31, 2025 107.09 Mn
Dec 31, 2024 114.48 Mn
Sep 30, 2024 126.52 Mn
Jun 30, 2024 134.83 Mn
Mar 31, 2024 159.29 Mn
Dec 31, 2023 167.90 Mn
Sep 30, 2023 85.39 Mn
Jun 30, 2023 88.84 Mn
Mar 31, 2023 93.32 Mn
Dec 31, 2022 103.91 Mn
Sep 30, 2022 109.78 Mn
Jun 30, 2022 117.86 Mn
Mar 31, 2022 116.13 Mn
Dec 31, 2021 133.23 Mn
Sep 30, 2021 147.42 Mn
API Access

Quince Therapeutics, Inc. Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=QNCX&period=max&api_key=YOUR_API_KEY